Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies

Clinical Cancer Research

Volumn 3, Issue 4, 1997, Pages 523-530

  Watanabe, Kunihiko ^a,d   Sato, Kazufumi ^a   Biernat, Wojciech ^a   Tachibana, Osamu ^a   Von Ammon, Klaus ^c   Ogata, Nobuyoshi ^c   Yonekawa, Yasuhiro ^c   Kleihues, Paul ^a,b   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BIOPSY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUTATION; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ASTROCYTOMA; BIOPSY; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CODON; DISEASE PROGRESSION; EXONS; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETROSPECTIVE STUDIES; SEQUENCE DELETION; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030917734     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kleihues, P., Burger, P. C., and Scheithauer, B. W. Histological typing of tumours of the central nervous system. WHO International Histological Classification of Tumours, 2nd ed. Berlin: Springer-Verlag, 1993.
2. Kleihues, P., Burger, P. C., and Scheithauer, B. W. The new WHO classification of brain tumours. Brain Pathol., 3: 255-268, 1993.
3. Ohgaki, H., Schauble, B., zur Hausen, A., von Ammon, K., and Kleihues, P. Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch., 427: 113-118, 1995.
4. Collins, V. P. Amplified genes in human gliomas. Semin. Cancer Biol., 4: 27-32, 1993.
5. Reifenberger, J., Ring, G. U., Gies, U., Cobbers, L., Oberstrass, J., An, H. X., Niederacher, D., Wechsler, W., and Reifenberger, G. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J. Neuropathol. Exp. Neurol., 55: 822-831, 1996.
6. Watanabe, K., Tachibana, O., Sato, K., Yonekawa, Y., Kleihues, P., and Ohgaki, H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol., 6: 217-224, 1996.
7. van Meyel, D. J., Ramsay, D. A., Casson, A. G., Keeney, M., Chambers, A. F., and Caimcross, J. G. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J. Natl. Cancer Inst., 86: 1011-1017, 1994.
8. Brustle, O., Ohgaki, H., Schmitt, H. P., Walter, G. F., Ostertag, H., and Kleihues, P. Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Association with an activated K-ras gene. Cancer (Phila.), 69: 2385-2392, 1992.
9. Zariwala, M., Schmid, S., Pfaltz, M., Ohgaki, H., Kleihues, P., and Schafer, R. p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumours and lymph-node metastases. Int. J. Cancer, 56: 807-811, 1994.
10. Weston, A., Ling Cawley, H. M., Caporaso, N. E., Bowman, E. D., Hoover, R. N., Trump, B. F., and Harris, C. C. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis (Lond.), 15: 583-587, 1994.
11. Beckman, G., Birgander, R., Sjalander, A., Saha, N., Holmberg, P. A., Kivela, A., and Beckman, L. Is p53 polymorphism maintained by natural selection? Hum. Hered., 44: 266-270, 1994.
12. Kraus, J. A., Bolln, C., Wolf, H. K., Neumann, J., Kindermann, D., Fimmers, R., Forster, F., Baumann, A., and Schlegel, U. TP53 alterations and clinical outcome in low grade astrocytomas. Genes Chromosomes & Cancer, 10: 143-149, 1994.
13. Schlegel, U. p53: an important or most overvalued tumor gene? Laryngorhinootologie, 73: 651-653, 1994.
14. al Sarraj, S., and Bridges, L. R. p53 immunoreactivity in astrocytomas and its relationship to survival. Br. J. Neurosurg., 9: 143-149, 1995.
15. Chozick, B. S., Pezzullo, J. C., Epstein, M. H., and Finch, P. W. Prognostic implications of p53 overexpression in supratentorial astrocytic tumors. Neurosurgery, 35: 831-837, 1994.
16. Goh, H.-S., Yao, J., and Smith, D. R. p53 Point mutation and survival in colorectal cancer patients. Cancer Res., 55: 5217-5221, 1995.
17. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J., and Hayashi, S. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis (Lond.), 14: 1085-1089, 1993.
18. Jin, X., Wu, X., Roth, J. A., Amos, C. I., King, T. M., Branch, C., Honn, S. E., and Spitz, M. R. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis (Lond.), 16: 2205-2208, 1995.
19. Wu, W. J., Kakehi, Y., Habuchi, T., Kinoshita, H., Ogawa, O., Terachi, T., Huang, C. H., Chiang, C. P., and Yoshida, O. Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers. Jpn. J. Cancer Res., 86: 730-736, 1995.
20. von Deimling, A., Eibl, R. H., Ohgaki, H., Louis, D. N., von Ammon, K., Petersen, I., Kleihues, P., Chung, R. Y., Wiestier, O. D., and Seizinger, B. R. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res., 52: 2987-2990, 1992.
21. Louis, D. N. The p53 gene and protein in human brain tumors. J. Neuropathol. Exp. Neurol., 53: 11-21, 1994.
22. Newcomb, E. W., Madonia, W. J., Pisharody, S., Lang, F. F., Koslow, M., and Miller, D. C. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol., 3: 229-235, 1993.
23. Lang, F. F., Miller, D. C., Pisharody, S., Koslow, M., and Newcomb, E. W. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Oncogene, 9: 949-954, 1994.
24. Louis, D. N., von Deimling, A., Chung, R. Y., Rubio, M. P., Whaley, J. M., Eibl, R. H., Ohgaki, H., Wiestier, O. D., Thor, A. D., and Seizinger, B. R. Comparative study of p53 gene and protein alterations in human astrocytic tumors. J. Neuropathol. Exp. Neurol., 52: 31-38, 1993.
25. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., and Vogelstein, B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature (Lond.), 355: 846-847, 1992.
26. Hainaut, P. The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr. Opin. Oncol., 7: 76-82, 1995.
27. Seth, A., Palli, D., Mariano, J. M., Metcalf, R., Venanzoni, M. C., Blanchi, S., Kottaridis, S. D., and Papas, T. S. P53 gene mutations in women with breast cancer and a previous history of benign breast disease. Eur. J. Cancer, 30A: 808-812, 1994.
28. Oda, H., Nakatsuru, Y., and Ishikawa, T. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res., 55: 658-662, 1995.
29. Spruck, C. H., III, Rideout, W. M., III, Olumi, A. F., Ohneseit, P. F., Yang, A. S., Tsai, Y. C., Nichols, P. W., Horn, T., Hermann, G. G., Steven, K., Ross, R. K., Yu, M. C., and Jones, P. A. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res., 53: 1162-1166, 1993.
30. Takeshima, Y., Inai, K., Bennett, W. P., Metcalf, R. A., Welsh, J. A., Yonehara, S., Hayashi, Y., Fujihara, M., Yamakido, M., Akiyama, M., Tokuoka, S., Land, C. E., and Harris, C. C. p53 mutations in lung cancers from Japanese mustard gas workers. Carcinogenesis (Lond.), 15: 2075-2079, 1994.
31. Shibata, A., Ohneseit, P. F., Tsai, Y. C., Spruck, C. H., Nichols, P. W., Chiang, H. S., Lai, M. K., and Jones, P. A. Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis (Lond.), 15: 1085-1087, 1994.
32. Lantos, P. L., VandenBerg, S. R., and Kleihues, P. Tumours of the nervous system. In: D. I. Graham and P. L. Lantos (eds.), Greenfield's Neuropathology, 6th ed., Vol. 2, Chap. 9, pp. 583-879. London: Arnold, 1996.
33. Lane, D. P. Cancer. p53, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
34. Hartwell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 71: 543-546, 1992.
35. Schmidt, E. E., Ichimura, K., Reifenberger, G., and Collins, V. P. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54: 6321-6324, 1994.
36. Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K., Kinzler, K. W., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54: 6353-6358, 1994.
37. Ueki, K., Rubio, M.-P., Ramesh, V., Correa, K. M., Rutter, J. L., von Deimling, A., Buckler, A. J., Gusella, J. F., and Louis, D. N. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum. Mol. Genet., 3: 1841-1845, 1994.
38. von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Wiestler, O. D., and Seizinger, B. R. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res., 52: 4277-4279, 1992.
39. Pults, D., Brockmeyer, D., Tullous, M. W., Pedone, C. A., and Cawthon, R. M. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res., 52: 674-679, 1992.
40. Venter, D. J., and Thomas, D. G. Multiple sequential molecular abnormalities in the evolution of human gliomas. Br. J. Cancer, 63: 753-757, 1991.
41. von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Hoell, T., Chung, R. Y., Martuza, R. L., Schoenfeld, D. A., Yasargil, M. G., Wiestler, O. D., and Seizinger, B. R. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J. Neurosurg., 77: 295-301, 1992.
42. Henson, J. W., Schnitker, B. L., Correa, K. M., von Deimling, A., Fassbender, F., Xu, H-J., Benedict, W. F., Yandell, D. W., and Louis, D. N. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann. Neurol., 36: 714-721, 1994.
43. Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., and Louis, D. N. CDKN2/pl6 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res., 56: 150-153, 1996.
44. Reifenberger, G., Reifenberger, J., Ichimura, K., Meltzer, P. S., and Collins, V. P. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res., 54: 4299-4303, 1994.